Search Within

Katherine S Panageas

Formats
  1. Journal Article (320)
  2. Meeting Abstract (181)
  3. Editorial (5)
  4. Research Letter (5)
  5. Correspondence (4)
  6. Review (4)
  7. Book Section (3)
  8. Miscellaneous (1)
Groups
  1. Biostatistics Service (523)
  2. Epidemiology and Biostatistics (523)
  3. Population Sciences Research Program (523)
  4. Department of Medicine (306)
  5. Solid Tumor Oncology Division (264)
  6. GSK Faculty (189)

More Groups

People
  1. Anne Reiner (94)
  2. Jedd Wolchok (92)
  3. Lisa De Angelis (86)
  4. Paul Chapman (77)
  5. Michael Postow (66)
  6. Clifford Hudis (56)

More People

Years
  1. 2025 (19)
  2. 2024 (23)
  3. 2023 (28)
  4. 2022 (28)
  5. 2021 (34)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (109)
  2. Neuro-Oncology (42)
  3. Clinical Cancer Research (31)
  4. Annals of Surgical Oncology (28)
  5. Cancer (21)
  6. Breast Cancer Research and Treatment (20)

More Publications

Publishers
  1. American Society of Clinical Oncology (122)
  2. Oxford University Press (68)
  3. Springer (65)
  4. American Association for Cancer Research (56)
  5. Wiley Blackwell (38)
  6. American Medical Association (19)

More Publishers

Results (523)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Letrozole (L) with bevacizumab (B) is feasible in patients (pts) with hormone receptor-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Traina, T. A.; Rugo, H.; Caravelli, J.; Yeh, B.; Panageas, K.; Bruckner, J.; Norton, L.; Park, J.; Hudis, C.; Dickler, M.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • A pilot study of growth factor (GF) omission during paclitaxel (T) for women with early breast carcinoma (BC)
    Meeting Abstract

    Sugarman, S. M.; Wasserheit, C.; Hodgman, E.; Coglianese, M. E.; D'alessandro, A.; Fornier, M.; Troso-Sandoval, T.; D'Andrea, G.; Drullinsky, P.; Lake, D.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Phase II trial of extended-dosing temozolomide in patients with melanoma
    Meeting Abstract

    Rietschel, P.; Ejadi, S.; Wolchok, J.; Krown, S.; Gerst, S.; Jungbluth, A. A.; Busam, K.; Smith, K.; Panageas, K.; Chapman, P.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Patterns of first recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy
    Meeting Abstract

    Dalal, K. M.; Panageas, K. S.; Patel, A.; Brady, M. S.; Jaques, D. P.; Coit, D. G.
    Annals of Surgical Oncology (2006)

    Fulltext@MSK | Save
  • Methods of detection of recurrence in patients with cutaneous melanoma
    Meeting Abstract

    Dalal, K. M.; Panageas, K. S.; Brady, M. S.; Jaques, D. P.; Coit, D. G.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Estimating survival probability in stage III melanoma: A multivariable individualized patient risk assessment nomogram
    Meeting Abstract

    Coit, D. G.; Zhou, C. Q.; Patel, A.; Panageas, K.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Prognostic model for primary CNS lymphoma (PCNSL): Recursive partitioning analysis (RPA) of the MSKCC PCNSL population
    Meeting Abstract

    Abrey, L. E.; BenPorat, L.; Panageas, K. S.; Yahalom, J.; Deangelis, L. M.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • In vitro expansion of Ag-specific T cells by HLA-A* 0201-transfected K562 cells for immune monitoring
    Journal Article

    Yuan, J.; Gallardo, H. F.; Rasalan, T.; Ranganathan, R.; Wang, J.; Zhang, Y.; Panageas, K.; Stan, R.; Young, J. W.; Houghton, A. N.; more...
    Cytotherapy (2006)

    Fulltext@MSK | Save
  • Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor κB ligand (RANKL) in human breast tumours
    Journal Article

    Van Poznak, C.; Cross, S. S.; Saggese, M.; Hudis, C.; Panageas, K. S.; Norton, L.; Coleman, R. E.; Holen, I.
    Journal of Clinical Pathology (2006)

    Fulltext@MSK | Save
  • The serum IL-12:IL-6 ratio reliably distinguishes infectious from non-infectious causes of fever during autologous stem cell transplantation
    Journal Article

    Tuma, R. A.; Almyroudis, N. G. ; Sohn, S. J.; Panageas, K.; Rice, R. D.; Galinkin, D.; Blain, M.; Montefusco, M.; Pamer, E. G.; Nimer, S. D.; more...
    Cytotherapy (2006)

    Fulltext@MSK | Save